ImpediMed

Recent Finacing

Equity

Recent Raise

$15M

ImpediMed develops bioimpedance spectroscopy-based medical devices and the SOZO digital health platform, providing FDA-cleared, CE-marked assessments of fluid status and body composition for lymphedema, heart failure, and malnutrition.

Founded 1999

California, United States

51-100

Publicly Traded

impedimed.com

Highlights

Focus Areas

Health Diagnostics

Manufacturing

Medical Device

Recent Investors

Financials

$15M

Total Raised

1

Funding round

1

Investor

Team

Upgrade to view the team

See the team members at ImpediMed.